RecruitingNot applicableNCT06001281

Predictive Value of Soluble CD146 in Glioblastoma Patients

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique Hopitaux De Marseille
Principal Investigator
Emeline Tabouret
AP-HM
Intervention
plasma collection(other)
Enrollment
55 enrolled
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06001281 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Giant cell glioblastoma

← Back to all trials